Hualan Biological Vaccine Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 12, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020
Market Capitalization	12,483	10,418	16,680	17,832	-	-
Market Cap Growth	23.63%	-37.54%	-6.46%	-	-	-
Enterprise Value	9,407	8,180	14,346	15,905	-	-
Last Close Price	20.98	16.80	25.82	27.44	-	-
PE Ratio	177.16	50.69	19.40	34.32	-	-
Forward PE	11.59	9.86	15.22	-	-	-
PS Ratio	12.78	9.24	6.92	9.77	-	-
PB Ratio	2.20	1.73	2.66	3.24	-	-
P/TBV Ratio	2.21	1.74	2.67	3.26	-	-
P/FCF Ratio	44.26	25.02	20.21	90.98	-	-
P/OCF Ratio	41.70	22.26	18.78	61.78	-	-
EV/Sales Ratio	9.63	7.25	5.95	8.71	-	-
EV/EBITDA Ratio	154.50	34.81	14.03	24.91	-	-
EV/EBIT Ratio	-	86.43	16.27	31.55	-	-
EV/FCF Ratio	33.36	19.64	17.38	81.14	-	-
Debt / Equity Ratio	-	0.05	0.05	0.06	0.18	0.09
Debt / EBITDA Ratio	-	1.28	0.29	0.47	0.68	0.18
Debt / FCF Ratio	-	0.72	0.36	1.53	-	1.24
Asset Turnover	0.13	0.14	0.32	0.32	0.45	0.89
Inventory Turnover	1.13	1.50	2.24	2.69	4.64	5.71
Quick Ratio	3.02	3.19	2.73	2.57	1.43	1.65
Current Ratio	3.26	3.40	3.10	2.73	1.51	1.70
Return on Equity (ROE)	1.20%	3.35%	14.63%	12.51%	24.86%	53.63%
Return on Assets (ROA)	-0.67%	0.76%	7.32%	5.43%	10.28%	24.23%
Return on Invested Capital (ROIC)	-2.92%	2.58%	19.83%	14.81%	30.53%	73.15%
Return on Capital Employed (ROCE)	-1.40%	1.60%	14.00%	9.10%	23.60%	48.10%
Earnings Yield	0.56%	1.97%	5.16%	2.91%	-	-
FCF Yield	2.26%	4.00%	4.95%	1.10%	-	-
Dividend Yield	2.86%	1.19%	2.32%	0.73%	-	-
Payout Ratio	196.37%	162.67%	13.95%	17.49%	2.06%	0.50%
Buyback Yield / Dilution	1.11%	0.71%	-2.03%	-9.33%	-0.01%	0.24%
Total Shareholder Return	3.96%	1.91%	0.29%	-8.61%	-0.01%	0.24%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.